Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)

Alejandra González-Duarte; John L. Berk; Dianna Quan; Michelle L. Mauermann; Hartmut H. Schmidt; Michael Polydefkis; Márcia Waddington-Cruz; Mitsuharu Ueda; Isabel M. Conceição; Arnt V. Kristen; Teresa Coelho; Cécile A. Cauquil; Céline Tard; Madeline Merkel; Emre Aldinc; Jihong Chen; Marianne T. Sweetser; Jing Jing Wang; David Adams

doi:10.1007/s00415-020-09715-5

Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)

Alejandra González-Duarte, John L. Berk, Dianna Quan, Michelle L. Mauermann, Hartmut H. Schmidt, Michael Polydefkis, Márcia Waddington-Cruz, Mitsuharu Ueda, Isabel M. Conceição, Arnt V. Kristen, Teresa Coelho, Cécile A. Cauquil, Céline Tard, Madeline Merkel, Emre Aldinc, Jihong Chen, Marianne T. Sweetser, Jing Jing Wang, David Adams

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The original version of this article unfortunately contained a mistake in Table 1. Units for albumin were given as g/dL. It should be g/L.

Original language	English (US)
Pages (from-to)	713-714
Number of pages	2
Journal	Journal of Neurology
Volume	267
Issue number	3
DOIs	https://doi.org/10.1007/s00415-020-09715-5
State	Published - Mar 1 2020

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1007/s00415-020-09715-5

Fingerprint

Dive into the research topics of 'Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)'. Together they form a unique fingerprint.

Cite this

González-Duarte, A., Berk, J. L., Quan, D., Mauermann, M. L., Schmidt, H. H., Polydefkis, M., Waddington-Cruz, M., Ueda, M., Conceição, I. M., Kristen, A. V., Coelho, T., Cauquil, C. A., Tard, C., Merkel, M., Aldinc, E., Chen, J., Sweetser, M. T., Wang, J. J., & Adams, D. (2020). Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8). Journal of Neurology, 267(3), 713-714. https://doi.org/10.1007/s00415-020-09715-5

Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8). / González-Duarte, Alejandra; Berk, John L.; Quan, Dianna et al.
In: Journal of Neurology, Vol. 267, No. 3, 01.03.2020, p. 713-714.

Research output: Contribution to journal › Comment/debate › peer-review

González-Duarte, A, Berk, JL, Quan, D, Mauermann, ML, Schmidt, HH, Polydefkis, M, Waddington-Cruz, M, Ueda, M, Conceição, IM, Kristen, AV, Coelho, T, Cauquil, CA, Tard, C, Merkel, M, Aldinc, E, Chen, J, Sweetser, MT, Wang, JJ & Adams, D 2020, 'Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)', Journal of Neurology, vol. 267, no. 3, pp. 713-714. https://doi.org/10.1007/s00415-020-09715-5

González-Duarte A, Berk JL, Quan D, Mauermann ML, Schmidt HH, Polydefkis M et al. Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8). Journal of Neurology. 2020 Mar 1;267(3):713-714. doi: 10.1007/s00415-020-09715-5

González-Duarte, Alejandra ; Berk, John L. ; Quan, Dianna et al. / Correction to : Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8). In: Journal of Neurology. 2020 ; Vol. 267, No. 3. pp. 713-714.

@article{9e9daff1f10a46a7bc5cc6480656b00a,

title = "Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)",

abstract = "The original version of this article unfortunately contained a mistake in Table 1. Units for albumin were given as g/dL. It should be g/L.",

author = "Alejandra Gonz{\'a}lez-Duarte and Berk, {John L.} and Dianna Quan and Mauermann, {Michelle L.} and Schmidt, {Hartmut H.} and Michael Polydefkis and M{\'a}rcia Waddington-Cruz and Mitsuharu Ueda and Concei{\c c}{\~a}o, {Isabel M.} and Kristen, {Arnt V.} and Teresa Coelho and Cauquil, {C{\'e}cile A.} and C{\'e}line Tard and Madeline Merkel and Emre Aldinc and Jihong Chen and Sweetser, {Marianne T.} and Wang, {Jing Jing} and David Adams",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = mar,

day = "1",

doi = "10.1007/s00415-020-09715-5",

language = "English (US)",

volume = "267",

pages = "713--714",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "D. Steinkopff-Verlag",

number = "3",

}

TY - JOUR

T1 - Correction to

T2 - Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)

AU - González-Duarte, Alejandra

AU - Berk, John L.

AU - Quan, Dianna

AU - Mauermann, Michelle L.

AU - Schmidt, Hartmut H.

AU - Polydefkis, Michael

AU - Waddington-Cruz, Márcia

AU - Ueda, Mitsuharu

AU - Conceição, Isabel M.

AU - Kristen, Arnt V.

AU - Coelho, Teresa

AU - Cauquil, Cécile A.

AU - Tard, Céline

AU - Merkel, Madeline

AU - Aldinc, Emre

AU - Chen, Jihong

AU - Sweetser, Marianne T.

AU - Wang, Jing Jing

AU - Adams, David

PY - 2020/3/1

Y1 - 2020/3/1

N2 - The original version of this article unfortunately contained a mistake in Table 1. Units for albumin were given as g/dL. It should be g/L.

AB - The original version of this article unfortunately contained a mistake in Table 1. Units for albumin were given as g/dL. It should be g/L.

UR - http://www.scopus.com/inward/record.url?scp=85079125440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079125440&partnerID=8YFLogxK

U2 - 10.1007/s00415-020-09715-5

DO - 10.1007/s00415-020-09715-5

M3 - Comment/debate

C2 - 32030522

AN - SCOPUS:85079125440

SN - 0340-5354

VL - 267

SP - 713

EP - 714

JO - Journal of Neurology

JF - Journal of Neurology

IS - 3

ER -

Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis (Journal of Neurology, (2020), 267, 3, (703-712), 10.1007/s00415-019-09602-8)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this